Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Byryzn + lidocaine
- Development stage
- Unknown
- Lead developer
- Hugel
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Administration
- Intradermal
01
Overview
Byryzn + lidocaine is a hyaluronic acid-based dermal filler developed by Hugel and manufactured by ACROSS. It is designed for the temporary improvement of facial wrinkles and skin quality enhancement through intradermal micropuncture injections. The formulation consists of cross-linked hyaluronic acid, a naturally occurring polysaccharide that provides hydration and restores volume to aging skin by binding water molecules. It also includes lidocaine, which acts as a local anesthetic by blocking sodium channels to reduce pain during the injection process. The product was approved in South Korea in 2021 for aesthetic applications.
- Brand names
- BYRYZN SKINBOOSTER HA
- Other names
- Byryzn (+Lidocaine)
02
Targets
SCN5A (Sodium channel protein type 5 subunit alpha)
Beyond the preview
Go deeper on Byryzn + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Byryzn + lidocaine.